Suggestions
Jangela Shumskas
Senior Strategist I National Security I Health Security
Jangela Shumskas is an experienced professional in the fields of innovation, technology, and entrepreneurship. She has over 20 years of experience driving innovative initiatives and creating programs that advocate for basic research investments and move revolutionary technologies to market.1
Some key points about Jangela Shumskas:
Professional Experience
- Executive Director at ByteCubed Ventures2
- Senior Advisor at BARDA DRIVe (Biomedical Advanced Research and Development Authority)3
- Founder & Principal at Kali Group1
Expertise
- Creating and implementing programs that integrate innovative technologies, startups, and federally funded programs2
- Providing strategic direction on innovative initiatives
- Judging ideas for distinctiveness, relevance, and validity
- Defining, refining, and improving entrepreneurial and innovative strategies
Education and Certifications
- MA in Strategic Security Studies from the National Defense University, College of International Security Affairs (concentration in International Security and Conflict Management & Security Operations)1
- Certified lean entrepreneurship instructor, mentored through Steve Blank's non-profit Venture Well1
Notable Engagements
Jangela has participated in various speaking engagements and panels, including:
- Moderator at Biomedical Advanced Research and Development Authority Industry Day
- Speaker and Moderator at DoD Beyond Phase II Conference
- Speaker at DoD Small Business Training Week
- Panelist at SBIR New England Regional Summit, Massachusetts Institute of Technology
- Review Committee Member for SXSW Health
- Judge/Reviewer for MedTech Innovator1
Jangela is known for her ability to understand the intersection between creativity, brand, business, customers, and technology.1 She is passionate about science, technology, and startups, describing herself as a "Science, tech & start-up junkie" on her Twitter profile.4
Highlights
Apr 13 · 19thnews.org
The U.S. is recommending pausing Johnson & Johnson's COVID ...